Both in Pharmaceuticals
Savara vs Corvus Pharmaceuticals
Over the past year SVRA returned −3.2% and CRVS returned +43.3%; their daily moves had a correlation of 0.24.
SVRA −3.2% CRVS +43.3%Growth of $1, one year, split-adjusted
| Metric | SVRA | CRVS |
|---|---|---|
| Price | $4.22 | $10.53 |
| Market cap | $867.0M | $885.8M |
| Today | −7.05% | −1.13% |
| 1 month | −16.8% | −10.8% |
| 6 months | −17.6% | −34.5% |
| Year to date | −30.0% | +36.8% |
| 1 year | +2.7% | +46.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $142.9M | $215.2M |
| Dividend yield | — | — |
| Volatility (60d) | 44.5% | 52.2% |
| Short % of float | 30.4% | 25.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).